Добавил:
ivanov666
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Инновационные технологии изучения сердечно-сосудистой системы и механизмов ее регуляции. Научно-практические и учебно-методические рекомендации по рез
.pdf
ɋɉɂɋɈɄ ɅɂɌȿɊȺɌɍɊɕ
12. Ɋɨɣɬɛɟɪɝ Ƚ. ȿ., ɋɬɪɭɬɵɧɫɤɢɣ Ⱥ. ȼ. ȼɧɭɬɪɟɧɧɢɟ ɛɨɥɟɡɧɢ. ɋɟɪɞɟɱɧɨɫɨɫɭɞɢɫɬɚɹ ɫɢɫɬɟɦɚ. Ɇ.: Ȼɢɧɨɦ, 2003.
13. Ɋɹɛɵɤɢɧɚ Ƚ. ȼ., ɋɨɛɨɥɟɜ Ⱥ. ȼ. ȼɚɪɢɚɛɟɥɶɧɨɫɬɶ ɪɢɬɦɚ ɫɟɪɞɰɚ. Ɇ.: ɋɬɚɪ’ɤɨ, 1998.
14. ɋɚɩɪɨɧɨɜɚ Ⱥ. ə., ɍɝɪɸɦɨɜ Ɇ. ȼ., Ʉɨɡɢɧɚ ȿ. Ⱥ. ɢ ɞɪ. ȼɵɞɟɥɟɧɢɟ ɞɨɮɚɦɢɧɚ
ɜ ɱɟɪɧɨɣ ɫɭɛɫɬɚɧɰɢɢ ɢ ɫɬɪɢɚɬɭɦɟ ɧɚ ɞɨɫɢɦɩɬɨɦɧɨɣ ɢ ɪɚɧɧɟɣ ɫɢɦɩɬɨɦɧɨɣ
ɫɬɚɞɢɹɯ ɩɚɪɤɢɧɫɨɧɢɡɦɚ ɭ ɦɵɲɟɣ // ɇɟɣɪɨɯɢɦɢɹ. 2011. ʋ 28(1). ɋ. 42–27.
15. ɋɢɬɧɢɤɨɜɚ ȿ. ɘ., Ƚɪɭɛɨɜ ȼ. ȼ., ɏɪɚɦɨɜ Ⱥ. ȿ., Ʉɨɪɨɧɨɜɫɤɢɣ Ⱥ. A. // ɀɭɪɧɚɥ
ɜɵɫɲɟɣ ɧɟɪɜɧɨɣ ɞɟɹɬɟɥɶɧɨɫɬɢ. 2012. ʋ 62(6). ɋ. 733–744.
16. ɋɨɥɨɜɶɟɜɚ Ⱥ. Ⱦ., Ⱦɚɧɢɥɨɜ Ⱥ. Ȼ., ɏɚɫɩɟɤɨɜɚ ɇ. Ȼ. ȼɟɝɟɬɚɬɢɜɧɵɟ ɪɚɫɫɬɪɨɣ-
ɫɬɜɚ: Ʉɥɢɧɢɤɚ, ɞɢɚɝɧɨɫɬɢɤɚ, ɥɟɱɟɧɢɟ / ɉɨɞ ɪɟɞ. Ⱥ. Ɇ. ȼɟɣɧɚ. Ɇ.: ɆɂȺ,
2003. ɋ. 44–102.
17. ɋɭɫɥɢɧɚ Ɂ. Ⱥ. ɋɨɫɭɞɢɫɬɵɟ ɡɚɛɨɥɟɜɚɧɢɹ ɝɨɥɨɜɧɨɝɨ ɦɨɡɝɚ ɜ Ɋɨɫɫɢɢ: ɧɟɤɨɬɨɪɵɟ ɢɬɨɝɢ ɢ ɩɟɪɫɩɟɤɬɢɜɵ // Ɍɟɪɚɩɟɜɬɢɱɟɫɤɢɣ ɚɪɯɢɜ. 2008. ʋ 10. ɋ. 5–8.
18. ɋɭɫɥɢɧɚ Ɂ. Ⱥ., Ƚɟɪɚɫɤɢɧɚ Ʌ. Ⱥ., Ɏɨɧɹɤɢɧ Ⱥ. ȼ. ɂɲɟɦɢɱɟɫɤɢɣ ɢɧɫɭɥɶɬ
ɢ ɫɟɪɞɰɟ: ɨɬ ɩɚɬɨɝɟɧɟɡɚ ɤ ɩɪɨɮɢɥɚɤɬɢɤɟ // Ʉɥɢɧɢɱɟɫɤɚɹ ɮɚɪɦɚɤɨɥɨɝɢɹ
ɢ ɬɟɪɚɩɢɹ. 2003. ʋ 5. ɋ. 47–51.
19. ɋɭɫɥɢɧɚ Ɂ. Ⱥ., Ƚɟɪɚɫɤɢɧɚ Ʌ. Ⱥ., Ɏɨɧɹɤɢɧ Ⱥ. ȼ. Ɉɫɨɛɟɧɧɨɫɬɢ ɤɚɪɞɢɚɥɶɧɨɣ
ɩɚɬɨɥɨɝɢɢ ɩɪɢ ɪɚɡɥɢɱɧɵɯ ɩɚɬɨɝɟɧɟɬɢɱɟɫɤɢɯ ɩɨɞɬɢɩɚɯ ɢɲɟɦɢɱɟɫɤɨɝɨ ɢɧɫɭɥɶɬɚ // ɇɟɜɪɨɥɨɝɢɱɟɫɤɢɣ ɠɭɪɧɚɥ. 2001. ʋ 5. ɋ. 12–15.
20. ɋɭɫɥɢɧɚ Ɂ. Ⱥ., Ɏɨɧɹɤɢɧ Ⱥ. ȼ., Ƚɟɪɚɫɤɢɧɚ Ʌ. Ⱥ. Ʉɚɪɞɢɨɧɟɜɪɨɥɨɝɢɹ: ɫɨɜɪɟ-
ɦɟɧɧɨɟ ɫɨɫɬɨɹɧɢɟ ɢ ɩɟɪɫɩɟɤɬɢɜɧɵɟ ɧɚɩɪɚɜɥɟɧɢɹ // ȼɟɫɬɧɢɤ Ɋɨɫɫɢɣɫɤɨɣ
Ⱥɤɚɞɟɦɢɢ ɦɟɞɢɰɢɧɫɤɢɯ ɧɚɭɤ. 2012. ʋ 2. ɋ. 4–10.
21. ɍɝɪɸɦɨɜ Ɇ. ȼ. ɗɤɫɩɪɟɫɫɢɹ ɮɟɪɦɟɧɬɨɜ ɫɢɧɬɟɡɚ ɞɨɮɚɦɢɧɚ
ɜ ɧɟɞɨɮɚɦɢɧɟɪɝɢɱɟɫɤɢɯ ɧɟɣɪɨɧɚɯ: ɮɭɧɤɰɢɨɧɚɥɶɧɨɟ ɡɧɚɱɟɧɢɟ ɢ ɪɟɝɭɥɹɰɢɹ
// ɍɫɩɟɯɢ ɮɢɡɢɨɥ. ɧɚɭɤ. 2007. ʋ 38(4). ɋ. 3–20.
22. Ɏɨɧɹɤɢɧ Ⱥ. ȼ., Ƚɟɪɚɫɤɢɧɚ Ʌ. Ⱥ. ɋɨɜɪɟɦɟɧɧɵɟ ɡɚɞɚɱɢ ɤɚɪɞɢɨɧɟɜɪɨɥɨɝɢɢ //
Ⱥɬɦɨɫɮɟɪɚ. ɇɟɪɜɧɵɟ ɛɨɥɟɡɧɢ. 2005. ʋ 2. ɋ. 18–25.
23. Ɏɨɧɹɤɧɧ Ⱥ. ȼ., Ƚɟɪɚɫɤɢɧɚ Ʌ. Ⱥ., ɋɭɫɥɢɧɚ Ɂ. Ⱥ. Ƚɟɦɨɞɢɧɚɦɢɱɟɫɤɚɹ ɨɰɟɧɤɚ
ɩɚɪɨɤɫɢɡɦɚɥɶɧɵɯ ɧɚɪɭɲɟɧɢɣ ɪɢɬɦɚ ɢ ɷɩɢɡɨɞɨɜ ɧɟɦɨɣ ɢɲɟɦɢɢ ɦɢɨɤɚɪɞɚ
ɭ ɛɨɥɶɧɵɯ ɫ ɢɲɟɦɢɱɟɫɤɢɦ ɢɧɫɭɥɶɬɨɦ (ɩɪɢɦɟɧɟɧɢɟ ɛɢɦɨɧɢɬɨɪɢɪɨɜɚɧɢɹ
ɗɄȽ ɢ ȺȾ) // ȼɟɫɬɧɢɤ ɚɪɢɬɦɨɥɨɝɢɢ. 2000. ʋ 19. ɋ. 36–41.
71
Ɇ.Ʌ. ɆȺɆȺɅɕȽȺ. ɂɇɇɈȼȺɐɂɈɇɇɕȿ ɌȿɏɇɈɅɈȽɂɂ ɂɁɍɑȿɇɂə ɋȿɊȾȿɑɇɈ-ɋɈɋɍȾɂɋɌɈɃ ɋɂɋɌȿɆɕ
ɂ ɆȿɏȺɇɂɁɆɈȼ ȿȿ ɊȿȽɍɅəɐɂɂ
24. ɏɚɢɧɞɪɚɜɚ ȼ. Ƚ., Ʉɨɡɢɧɚ ȿ. Ⱥ., Ʉɭɱɟɪɹɧɭ ȼ. Ƚ. ɢ ɞɪ. Ɇɨɞɟɥɢɪɨɜɚɧɢɟ ɩɪɟ-
ɤɥɢɧɢɱɟɫɤɨɣ ɢ ɪɚɧɧɟɣ ɤɥɢɧɢɱɟɫɤɨɣ ɫɬɚɞɢɣ ɛɨɥɟɡɧɢ ɉɚɪɤɢɧɫɨɧɚ // ɀɭɪɧɚɥ
ɧɟɜɪɨɥɨɝɢɢ ɢ ɩɫɢɯɢɚɬɪɢɢ ɢɦ. ɋ. ɋ. Ʉɨɪɫɚɤɨɜɚ. 2010. ʋ 110(7). ɋ. 41–47.
25. ɒɚɭɰɭɤɨɜɚ Ʌ. Ɂ. Ɏɢɡɢɨɥɨɝɢɹ ɫɟɪɞɟɱɧɨ-ɫɨɫɭɞɢɫɬɨɣ ɫɢɫɬɟɦɵ. ɇɚɥɶɱɢɤ: ɗɥɶ-Ɏɚ,
2005
26. Akaln F., Trtr A., Ylmaz Y. Increased QT dispersion in epileptic children.
Acta Pediatric. 2003. 92(8): 916–920.
27. Aker R. G., Onat F. Y. Cardiovascular regulation through hypothalamic GABA(A) receptors in a genetic absence epilepsy model in rat. Epilepsia. 2002.
43(2): 107–14.
28. Algeri S., Ambrosio S., Garofalo P. et al. Peripheral effects of 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its main metabolite 1-methyl-4phenylpyridinium ion (MPP+) in the rat. European Journal of Pharmacology.
1987. 141(2): 309–331.
29. Ambrosio S., Blesa R., Mintenig G. M. et al. Acute effects of 1-methyl-4phenyl-1,2,3,6-tetra-hydropyridine (MPTP) on catecholamines in heart, adrenal
gland, retina and caudate nucleus of the cat. Toxicology Letters. 1988. 44(1–2):
1–6.
30. Bealer S. L., Little J. G., Metcalf C. S, Brewster A. L., Anderson A. E. // Epi-
lepsy Research. 2010. 91(1): 66–73.
31. Bhidayasiri R., Truong D. D. Therapeutic strategies for nonmotor symptoms in
early Parkinson's disease: the case for a higher priority and stronger evidence.
Parkinsonism Relat. Disord. 2012. 18(1): 110–113.
32. Blumenfeld H., McCormick D. A. Corticothalamic inputs control the pattern of activity generated in thalamocortical networks. J Neurosci. 2000. 20(13): 5153í5162.
33. Brotherstone R., Blackhall B., McLellan A. Lengthening of corrected QT during
epileptic seizures. Epilepsia. 2010. 51(2): 221–232.
34. Chaturvedi S. Should stroke be considered both a brain attack and a heart attack? Stroke. 2007. 38(7): 1713–1714.
35. Cockerall O. C., Johnson A., Sander J. W. Mortality from epilepsy: results from
a prospective population-based study. Lancet. 1994. 344(8927): 918–921.
72
ɋɉɂɋɈɄ ɅɂɌȿɊȺɌɍɊɕ
36. Coenen A. M. L., van Luijtelaar E. L. J. M. Genetic animal models for absence
epilepsy: a review of the WAG/Rij strain of rats. Behav. Genet. 2003. 33(6):
635–655.
37. DeGiorgio Ch. M., Miller P., Meymandi Sh. et al. RMSSD, a measure of vagusmediated heart rate variability, is associated with risk factors for SUDEP: the
SUDEP-7 Inventory. Epilepsy Behavior. 2010. 19(1): 78–88.
38. Deguchi K., Sasaki I., Tsukaguchi M. et al. Abnormalities of rate-corrected QT
intervals in Parkinson's disease – a comparison with multiple system atrophy
and progressive supranuclear palsy. Journal of the Neurological Sciences. 2002.
199(1–2): 31–37.
39. Dekker J. M., Crow R. S., Folsom A. R. et al. Low heart Rate Variability in a 2-
Minute Rhythm Strip Predicts Risk of Coronary Heart Disease and Mortality
From Severel Causes: The ARIC Study. Circulation. 2000. 102(11): 1239–1244.
40. Devos D., Kroumova M., Bordet R. et al. Heart rate variability and Parkinson's
disease severity. J. Neural. Transm. 2003. 110(9): 997–1011.
41. Dhamoon M. S., Sciacca R. R., Rundek T. et al. Recurrent stroke and cardiac
risks after first ischemic stroke: The Northern Manhattan Study. Neurology.
2006. 66(14): 641–646.
42. Dhamoon M. S., Tai W., Boden-Albala B. et al. Risk of myocardial infarction or
vascular death after first ischemic stroke: The Northern Manhattan study.
Stroke. 2007. 38(6): 1752–1758.
43. Drinkenburg W. H. I. M., Coenen A. M. L., Vossen J. M. H., Van Luijtelaar E.
L. J. M. Spike-wave discharges and sleep-wake states in rats with absence epilepsy. Epilepsy Res. 1991. 9(3): 218–224.
44. Elmpt W. J. C., Nijsen T. M. E., Griep P. A. M., Arends M. J. B. // Seizure.
2006. 15(6): 366–375.
45. Everett K., Chioza B., Aicardi J. et al. Linkage and mutation analysis of CLCN2
in childhood absence epilepsy. Epilepsy Res. 2007. 75(2–3): 145–153.
46. Evrengul H., Tanriverdi H., Dursunoglu D. et al. Time and frequency domain
analyses of heart rate variability in patients with epilepsy. Epilepsy Res. 2005.
63(2–3): 131–139.
73
Ɇ.Ʌ. ɆȺɆȺɅɕȽȺ. ɂɇɇɈȼȺɐɂɈɇɇɕȿ ɌȿɏɇɈɅɈȽɂɂ ɂɁɍɑȿɇɂə ɋȿɊȾȿɑɇɈ-ɋɈɋɍȾɂɋɌɈɃ ɋɂɋɌȿɆɕ
ɂ ɆȿɏȺɇɂɁɆɈȼ ȿȿ ɊȿȽɍɅəɐɂɂ
47. Fuller R. W., Hemrick-Luecke S. K., Perry K. W. Deprenyl antagonizes acute
lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. J Pharmacol
Exp Ther. 1988. 247(2): 531–535.
48. Gibbs F. A., Davis H., Lennox W. G. The electroencephalogramin epilepsy and
in conditions of impaired consciousness. Archives of neurology and Psychiatry
(Chicago). 1935. 34. 11–33.
49. Graff B., Gąsecki D., Rojek A. et al. Heart rate variability and functional outcome in ischemic stroke: a multiparameter approach. Journal of Hypertension.
2013. 31(8): 1629–1636.
50. Griffiths G. M., Fox J. T. Rhythm in epilepsy. Lancet. 1938. 232(5999): 409–416.
51. Haapaniemi T. H., Pursiainen V., Korpelainen J. T. et al. Ambulatory ECG and
analysis of heart rate variability in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2001. 70(3): 305–310.
52. Hallioglu O., Okuyaz C., Mert E. Makharoblidze K. Effects of antiepileptic drug
therapy on heart rate variability in children with epilepsy. Epilepsy Research.
2008. 79(1): 49–54.
53. Hankey G. J., Jamrozik K., Broadhurst R. J. et al. Five-year survival after firstever stroke and related prognostic factors in the Perth Community Stroke Study.
Stroke. 2000. 31(9): 2080–2086.
54. Jansen K., Varon C., Van Huffel S., Lagae L. Cardiac and respiratory auto-
nomic dysfunction in childhood epilepsy. European Journal of Pediatric Neurology. 2013. 17(1): 29–38.
55. Jansen K., Lagae L. Cardiac changes in epilepsy. Seizure. 2010. 19(8): 455–460.
56. Kheiri F., Bragin A., Engel J. J., Almajano J., Winden E. Non-linear classification ofheart rate parameters as a biomarker for epileptogenesis. Epilepsy Res.
2012. 100(1–2): 59–66.
57. Koskenvuo J. W., Mirsky R., Zhang Y. et al. A comparison of echocardiography
to invasive measurement in the evaluation of pulmonary arterial hypertension in
a rat model. Int J Cardiovasc Imaging. 2010. 26(5): 509–518.
58. Kuroiwa T., Xi G., Hua Y. et al. Development of a Rat Model of Photothrombotic
Ischemia and Infarction Within the Caudoputamen. Stroke. 2009. 40(1): 248–253.
74
ɋɉɂɋɈɄ ɅɂɌȿɊȺɌɍɊɕ
59. Lackland D. T., Elkind M. S., D’Agostino R. Sr. et al. Inclusion of stroke in
cardiovascular risk prediction instruments: A statement for healthcare professionals from the American Heart Association/American Stroke Association.
Stroke. 2012. 43(7): 1998–2027.
60. Lathers C. M., Schraeder P. L., Bungo M. W. The mystery of sudden death:
Mechanisms for risks. Epilepsy Behavior. 2008. 12(1): 3–24.
61. Lopinto-Khoury C., Mintzer S. Antiepileptic drugs and markers of vascular risk.
Curr Treat Options Neurol. 2010. 12(4): 300–308.
62. Lotufo P. A., Valiengo L., Benseñor I. M., Brunoni A. R. A systematic review
and meta-analysis of heart rate variability in epilepsy and antiepileptic drugs.
Epilepsia. 2012. 53(2): 272–282.
63. Luijtelaar E. L. J. M. van, Coenen A. M. L. Genetic models of absence epilepsy:
New concepts and insights. In Encyclopedia of Basic Epilepsy Res. Oxford:
Academic Press. 2009. 1–8.
64. Luijtelaar G. van, Sitnikova E. Global and focal aspects of absence epilepsy: the
contribution of genetic models. Neurosci Biobehav Rev. 2006. 30(7): 983–1003.
65. Mäkikallio A. M., Mäkikallio T. H., Korpelainen J. T. et al. Heart rate dynamics
predict poststroke mortality. Neurology. 2004. 62(10): 1822–1826.
66. Manev H. The Heart-Brain Connection Begets Cardiovascular Psychiatry and
Neurology Cardiovasc Psychiatry Neurol. 2009. 125: 343–347.
67. McLaren A., Kerr S., Allan L. et al. Autonomic Function Is Impaired in Elderly
Stroke Survivors. Stroke. 2005. 36(5): 1026–1030.
68. Meeren H. K., van Luijtelaar E. L. J. M., Lopes da Silva F. H., Coenen A. M.
Evolving concepts on the pathophysiology of absence seizures: the cortical focus theory. Arch Neurol. 2005. 62(3): 371–376.
69. Mokhles M. M., Trifirò G., Dieleman J. P. et al. The risk of new onset heart
failure associated with dopamine agonist use in Parkinson's disease. Pharmacological Research. 2012. 65(3): 358–364.
70. Monthly report on safety concerns, guidelines and general matters. European
medicines Agency. 2012. 1205.
75
Ɇ.Ʌ. ɆȺɆȺɅɕȽȺ. ɂɇɇɈȼȺɐɂɈɇɇɕȿ ɌȿɏɇɈɅɈȽɂɂ ɂɁɍɑȿɇɂə ɋȿɊȾȿɑɇɈ-ɋɈɋɍȾɂɋɌɈɃ ɋɂɋɌȿɆɕ
ɂ ɆȿɏȺɇɂɁɆɈȼ ȿȿ ɊȿȽɍɅəɐɂɂ
71. Moon S. K., Alaverdashvili M., Cross A. R., Whishaw I. Q. Both compensation
and recovery of skilled reaching following small photothrombotic stroke to motor cortex in the rat. Experimental Neurology. 2009. 218(1): 145–153.
72. Moseley B., Bateman L., Millichap J. J., Wirrell E., Panayiotopoulos Ch. P.
Autonomic epileptic seizures, autonomic effects of seizures, and SUDEP. Epilepsy Behavior. 2013. 26(3): 375–385.
73. Nagai M., Hoshide S., Kario K. The insular cortex and cardiovascular system: a
new insight into the brain-heart axis. Journal of the American Society of Hypertension. 2010. 4(4): 174–182.
74. National Heart Disease and Stroke Prevention Program. Staff Orientation. Guide
// National Center for Chronic Disease Prevention and Health Promotion. Division for Heart Disease and Stroke Prevention. Atlanta, USA. 2011. 56 p.
75. Ng C., Powell K., Jones N., Megatia I. et al. Brain and heart links: alterations in
cardiac function and HCN channel expression in genetic absence epilepsy rats
from Strasbourg. Journal of Clinical Neuroscience. 2009. 16(11): 15–20.
76. Oka H., Mochio S., Onouchi K. et al. Cardiovascular dysautonomia in de novo
Parkinson’s disease. Neurol Sci. 2006. 241(1–2): 59–65.
77. Opeskin K, Harvey A. S, Cordner S. M. et al. Sudden unexpected death in epilepsy in Victoria. J Clin Neurosci. 2000. 7(1): 34–37.
78. Pansani A. P., Colugnati D. B., Guus H. M. et al. Repeated amygdala-kindled
seizures induce ictal rebound tachycardia in rats. Epilepsy Behavior. 2011.
22(3): 442–449.
79. Ponnusamy A., Marques J. L., Reuber M. Comparison of heart rate variability
parameters during complex partial seizures and psychogenic nonepileptic seizures. Epilepsia. 2012. 53(8): 1314–1321.
80. Pradhan C., Sinha S., Thennarasu K., Jagadisha T. Quantitative analysis of heart rate
variability in patients with absence epilepsy. Neurology India. 2011. 59(1). 25–29.
81. Pursiainen V. Autonomic dysfunction in early and advanced Parkinson's disease
Oulun Yliopisto, Oulu. 2007.
76
ɋɉɂɋɈɄ ɅɂɌȿɊȺɌɍɊɕ
82. Quigg M. Circadian rhythms: interactions with seizures and epilepsy. Epilepsy
Res. 2000. 42(1): 43–55.
83. Ren J., Porter J. E., Wold L. E. et al. Depressed contractile function and adrenergic
responsiveness of cardiac myocytes in an experimental model of Parkinson disease,
the MPTP-treated mouse. Neurobiology of Aging. 2004. 25(1): 131–138.
84. Rieu I., Boirie Y., Morio B. et al. The Idiopathic Parkinson's disease: A meta-
bolic disease? Rev Neurol (Paris). 2010. 166(10): 822–828.
85. Ritz B., Rhodes S. L., Qian L. et al. L-type calcium channel blockers and Parkinson disease in Denmark. Ann. Neurol. 2010. 67(5): 600–606.
86. Ronkainen E., Korpelainen J. T., Heikkinen E. et al. Cardiac autonomic control
in patients with refractory epilepsy before and during vagus nerve stimulation
treatment: a one-year follow-up study. Epilepsia. 2006. 47(3): 556–562.
87. Sahin D., Ilbay G., Imal M. et al. Vagus nerve stimulation suppresses generalized seizure activity and seizure-triggered postictal cardiac rhythm changes in
rats. Physiol. Res. 2009. 58(3): 345–350.
88. Sajadieh A., Rasmussen V., Hein H. O., Hansen J. F. Familial Predisposition to
Premature Heart Attack and Reduced Heart Rate Variability. J Cardiol. 2003.
92(2): 234–236.
89. Samuels M. A. The Brain-Heart Connection. Circulation. 2007. 116(1): 77–84.
90. Sarkisova K., Luijtelaar G. The WAG/Rij strain: A genetic animal model of
absence epilepsy with comorbidity of depressiony Prog Neuropsychopharmacol
Biol Psychiatry. 2011. 35(4): 854–876.
91. Sayed H. L., Kotby A. A., Tomoum H. Y. et al. Non-invasive assessment of
cardioregulatory autonomic functions in children with epilepsy. Acta Neurol.
Scand. 2007. 115(6): 377–384.
92. Schuele S. U., Widdess-Walsh P., Bermeo A., Lüders H. O. Sudden unexplained
death in epilepsy: the role of the heart. Cleve Clin J Med. 2007. 74(1): 121–127.
93. Sevcencu C, Struijk JJ. Autonomic alterations and cardiac changes in epilepsy.
Epilepsia. 2010. 51(5): 725–737.
77
Ɇ.Ʌ. ɆȺɆȺɅɕȽȺ. ɂɇɇɈȼȺɐɂɈɇɇɕȿ ɌȿɏɇɈɅɈȽɂɂ ɂɁɍɑȿɇɂə ɋȿɊȾȿɑɇɈ-ɋɈɋɍȾɂɋɌɈɃ ɋɂɋɌȿɆɕ
ɂ ɆȿɏȺɇɂɁɆɈȼ ȿȿ ɊȿȽɍɅəɐɂɂ
94. Sitnikova E., Hramov A. E., Grubov V. V. et al. On-off intermittency of thalamocortical oscillations in the electroencephalogram of rats with genetic predisposition to absence epilepsy. Brain Res. 2012. 1436(3): 147–156.
95. Smyk M. K., Coenen A., Lewandowski M. H., Luijtelaar G. Endogenous
rhythm of absence epilepsy: Relationship with general motor activity and sleepwake states. Epilepsy Research. 2011. 93(2–3): 120–127.
96. Stewart M. Autonomic consequences of seizures, including sudden unexpected
death in epilepsy. In: Encyclopedia of Basic Epilepsy Research. ed. University
of California, Elsevier, USA. 2009. P. 1289–1294.
97. Tavernor S. J., Brown S. W., Tavernor R. M. E., Gifford C. Electrocardiograph
QT lengthening associated with epileptiform EEG discharges – a role in sudden
unexplained death in epilepsy? Seizure. 1996. 5(1): 79–83.
98. Tchekalarova J., Pechlivanova D., Itzev D. et al. Diurnal rhythms of spontaneous recurrent seizures and behavioral alterations of Wistar and spontaneously
hypertensive rats in the kainate model of epilepsy. Epilepsy Behav. 2010.
23(17): 23–32.
99. Terra V. C., Cysneiros R., Cavalheiro E. A., Scorza F. A. Sudden unexpected
death in epilepsy: From the lab to the clinic setting. Epilepsy Behavior. 2013.
26(3): 415–420.
100. Thayer J. F., Yamamoto S. S., Brosschot J. F. The relationship of autonomic
imbalance, heart rate variability and cardiovascular disease risk factors. Int J
Cardiol. 2010. 141(2): 122–131.
101. Tontodonati M., Fasdelli N., Repeto P., Dorigatti R. Characterisation of rodent
dobutamine echocardiography for preclinical safety pharmacology assessment.
Journal of Pharmacological and Toxicological Methods. 2011. 64(2): 129–133.
102. Touze E., Varenne O., Calvet D., Mas J. L. Coronary risk stratification in pa-
tients with ischemic stroke or transient ischemic stroke attack. Int. J Stroke.
2007. 2(3): 177–183.
103. Touze E., Varenne O., Mas J. L. Overestimation of coronary risk in stroke pa-
tients. Stroke. 2007. 38(10): 98–102.
78
ɋɉɂɋɈɄ ɅɂɌȿɊȺɌɍɊɕ
104. Towfighi A., Markovic D., Ovbiagele B. Utility of Framingham Coronary Heart
Disease Risk Score for Predicting Cardiac Risk After Stroke. Stroke. 2012.
43(11): 2942–2947.
105. Tsagalis G., Bakirtzi N., Spengos K. et al. Long-term prognosis of combined
chronic heart failure and chronic renal dysfunction after acute stroke. Eur J
Heart Fail. 2010. 12(8): 849–854.
106. Tsuji H., Larson M. G., Vendetti F. J. Jr. et al. Impact of Reduced Heart Rate
Variability on Risk for Cardiac Events. The Framingham Heart Study. Circulation. 1996. 94(11): 2850–2855.
107. Ugrumov M. V., Khaindrava V. G., Kozina E. A. et. al. Modeling of presymp-
tomatic and symptomatic stages of parkinsonism in mice. Neuroscience. 2011.
181(5): 175–188.
108. Wasterlain C. G., Fujikawa D. G., Penix L., Sankar R. Pathophysiological mechanisms of brain damage from status epilepticus. Epilepsia. 1993. 34(1): 37–53.
109. Watson B. D., Dietrich W. D., Busto R. et al. Induction of reproducible brain infarction by photochemically initiated thrombosis. Ann. Neurol. 1985. 17(5): 497–504.
110. Welsh D. K., Takahashi J. S., Kay S. A. Suprachiasmatic nucleus: cell autono-
my and network. Annu. Rev. Physiol. 2010. 72: 551–577.
111. Witt B. J., Brown R. D. Jr., Jacobsen S. J. et al. Ischemic stroke after heart failure:
A community-based study. American Heart Journal. 2006. 152(1): 102–109.
112.
Yananli H. R., Terzio÷lu B., Goren M. Z., Aker R. G., Aypak C., Onat F. Y.
Extracellular hypothalamic gamma-aminobutyric acid (GABA) and L-glutamic
acid concentrations in response to bicuculline in a genetic absence epilepsy rat
model. J. Pharmacol Sci. 2008. 106(2): 301–309.
79
Мамалыга Максим Леонидович
ИННОВАЦИОННЫЕ ТЕХНОЛОГИИ ИЗУЧЕНИЯ
СЕРДЕЧНО-СОСУДИСТОЙ СИСТЕМЫ
И МЕХАНИЗМОВ ЕЕ РЕГУЛЯЦИИ
Научно-практические и учебно-методические рекомендации
по результатам исследования
Редактор Дубовец В. В.
Оформление обложки Удовенко В. Г.
Компьютерная верстка Потрахов И. А.
Управление издательской деятельности
и инновационного проектирования МПГУ
119571, Москва, Вернадского пр-т, д. 88, оф. 446.
Тел.: (499) 730-38-61
E-mail: izdat@mpgu.edu
Подписано в печать 25.08.2014. Формат 60х90/16.
Бум. офсетная. Печать цифровая. Объем 5,0 п.л.
Тираж 500 экз. Заказ № 305.
Соседние файлы в предмете [НЕСОРТИРОВАННОЕ]